Cargando…
Heparin in malignant glioma: review of preclinical studies and clinical results
Glioblastoma multiforme (GBM) is the most common primary brain tumor that is invariably lethal. Novel treatments are desperately needed. In various cancers, heparin and its low molecular weight derivatives (LMWHs), commonly used for the prevention and treatment of thrombosis, have shown therapeutic...
Autores principales: | Schnoor, Rosalie, Maas, Sybren L. N., Broekman, Marike L. D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582077/ https://www.ncbi.nlm.nih.gov/pubmed/26123362 http://dx.doi.org/10.1007/s11060-015-1826-x |
Ejemplares similares
-
Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results
por: Senders, Joeky T., et al.
Publicado: (2016) -
Beta-blockers and glioma: a systematic review of preclinical studies and clinical results
por: Tewarie, Ishaan Ashwini, et al.
Publicado: (2020) -
Clinical challenges of glioma and pregnancy: a systematic review
por: van Westrhenen, A., et al.
Publicado: (2018) -
Versatile Role of Rab27a in Glioma: Effects on Release of Extracellular Vesicles, Cell Viability, and Tumor Progression
por: van Solinge, Thomas S., et al.
Publicado: (2020) -
Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?
por: Jessurun, Charissa A. C., et al.
Publicado: (2019)